B7H3 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young Adults

Conditions:   Pediatric Solid Tumor;   Germ Cell Tumor;   Retinoblastoma;   Hepatoblastoma;   Wilms Tumor;   Rhabdoid Tumor;   Carcinoma;   Osteosarcoma;   Ewing Sarcoma;   Rhabdomyosarcoma;   Synovial Sarcoma;   Clear Cell Sarcoma;   Malignant Peripheral Nerve Sheath Tumors;   Desm oplastic Small Round Cell Tumor;   Soft Tissue Sarcoma;   Neuroblastoma;   Melanoma Interventions:   Biological: second generation 4-1BBζ B7H3-EGFRt-DHFR;   Biological: second generation 4-1BBζ B7H3-EGFRt-DHFR(selected) and a second generation 4-1BBζ CD19-Her2tG Sponsor:   Seattle Children's Hospital Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials

Related Links:

More News: Bone Cancers | Brain | Cancer & Oncology | Carcinoma | Children | Eye Cancers | Hepatoblastoma | Hospitals | Immunotherapy | Melanoma | Neuroblastoma | Neurology | Osteosarcoma | Pediatrics | Research | Retinoblastoma | Rhabdomyosarcoma | Sarcomas | Skin Cancer